Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  CD19CAR-CD3zeta-4-1BB-expressing autologous T lymphocytes
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Determine Efficacy and Safety of CTL019 in Pediatric Patients With Relapsed and Refractory B-cell ALL
Status: Active
Phase: Phase II
Type: Treatment
Age: 3 to 21
Trial IDs: CCTL019B2202, NCI-2015-01235, NCI-2015-00434, NCI-2015-00551, NCI-2015-00552, NCT02435849
CD19-Specific T-cells in Treating Patients with Advanced Lymphoid Malignancies
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 to 80
Trial IDs: 2013-1018, NCI-2015-01492, 20152145, 1159157, NCT02529813
Laboratory Treated T-Cells in Treating Patients with Recurrent CD19+ Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Receiving Ibrutinib
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCC 18415, NCI-2016-00049, 18415, CTL019A2206J, NCT02640209
Start Over